The United States on Friday approved the first medicine to use gene editing tool CRISPR in a breakthrough for treatment of sickle cell disease, a debilitating inherited blood disorder. The US Food and Drug Administration said it had “approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of […]
The United States on Friday approved the first medicine to use gene editing tool CRISPR in a breakthrough for treatment of sickle cell disease, a debilitating inherited blood disorder. The US Food and Drug Administration said it had “approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of […]
The post US approves sickle cell breakthrough with gene editing therapy appeared first on Insider Paper.
https://insiderpaper.com/us-approves-sickle-cell-breakthrough-with-gene-editing-therapy/
Comments
0 comment